Medtronic (MDT) stock
Last close $99.94 on 2026-11-20 (-0.67%) · Sector: Healthcare
Medtronic is a large American medical device company, based in Minneapolis, that makes tools and equipment used in hospitals, such as heart devices, surgical systems, and diabetes products. It earns most of its money by selling these devices to hospitals, doctors, and patients around the world.
Medtronic's sales are growing, with revenue up 9.8% recently and a 65.0% gross margin showing healthy profit on each sale. The stock is up 3.2% over the past year, while the S&P 500 rose 3.15%, so it has lagged the broader market. The shares trade about 6.0% below their 52-week high, and insiders sold about $5.9M of stock in the last 90 days, including a $4.8M sale by the CEO. After its last three earnings reports, the stock rose the day after two times and fell once.
Key numbers
- Market cap: $128.4B
- Revenue (last 12 months): $37.55B
- Revenue growth: +9.8%
- Gross margin: 65.0%
- Operating margin: 18.1%
- P/E: 24.6
- P/S: 3.4
- Debt to equity: 0.44
- Current ratio: 2.07
Quality score
Overall 44/100 · growth 38 · profitability 42 · financial health 59 · value 38
Performance and risk
1-year return -3.2% vs S&P 500 +3.1% · volatility 25.2% (S&P 500 14.2%) · largest drop -30.0% · beta 0.15
Stock move the day after earnings
- 2026-02-17: -3.1%
- 2026-06-03: +5.7%
- 2026-09-01: +1.5%
Congress trades (90 days)
0 buys, 1 sells
Insider trades (12 months)
Bought $0.0M · sold $11.6M
MDT stock research · MDT options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.